TitleAssistant Professor
InstitutionMD Anderson
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hobbs BP, Pestana RC, Zabor EC, Kaizer AM, Hong DS. Basket Trials: Review of Current Practice and Innovations for Future Trials. J Clin Oncol. 2022 May 10; JCO2102285. PMID: 35537102.
      Citations:    Fields:    
    2. Ebrahimi S, Lim G, Hobbs BP, Lin SH, Mohan R, Cao W. A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy. Med Phys. 2022 May; 49(5):3507-3522. PMID: 35229311.
      Citations:    Fields:    Translation:Humans
    3. Wang X, Palaskas NL, Hobbs BP, Abe JI, Nead KT, Yusuf SW, Hermann J, Deswal A, Lin SH. The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer. Cancers (Basel). 2022 Mar 03; 14(5). PMID: 35267613.
      Citations: 1     
    4. Zabor EC, Kaizer AM, Garrett-Mayer E, Hobbs BP. Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts. JCO Precis Oncol. 2022 03; 6:e2100390. PMID: 35385345.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    5. Zabor EC, Kane MJ, Roychoudhury S, Nie L, Hobbs BP. Bayesian basket trial design with false-discovery rate control. Clin Trials. 2022 06; 19(3):297-306. PMID: 35128970.
      Citations:    Fields:    Translation:Humans
    6. Ghosh AJ, Hobbs BD, Moll M, Saferali A, Boueiz A, Yun JH, Sciurba F, Barwick L, Limper AH, Flaherty K, Criner G, Brown KK, Wise R, Martinez FJ, Lomas D, Castaldi PJ, Carey VJ, DeMeo DL, Cho MH, Silverman EK, Hersh CP. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022 02 01; 205(3):313-323. PMID: 34762809.
      Citations: 3     Fields:    Translation:Humans
    7. Zhou J, Jiang X, Xia HA, Wei P, Hobbs BP. Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response. Stat Med. 2022 02 20; 41(4):751-768. PMID: 34888892.
      Citations:    Fields:    Translation:Humans
    8. Wang X, Hobbs B, Gandhi SJ, Muijs CT, Langendijk JA, Lin SH. Current status and application of proton therapy for esophageal cancer. Radiother Oncol. 2021 11; 164:27-36. PMID: 34534613.
      Citations: 1     Fields:    Translation:Humans
    9. Zhu C, Mohan R, Lin SH, Jun G, Yaseen A, Jiang X, Wang Q, Cao W, Hobbs BP. Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning. JCO Clin Cancer Inform. 2021 09; 5:1044-1053. PMID: 34665662.
      Citations: 1     Fields:    Translation:Humans
    10. Zhou J, Jiang X, Amy Xia H, Wei P, Hobbs BP. A survival mediation model with Bayesian model averaging. Stat Methods Med Res. 2021 11; 30(11):2413-2427. PMID: 34448657.
      Citations: 1     Fields:    Translation:Humans
    11. Zhu L, Hobbs B, Roszik J, Holla V, Hong DS. Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors. Invest New Drugs. 2022 02; 40(1):157-162. PMID: 34341905.
      Citations:    Fields:    Translation:Humans
    12. Kurzrock R, Lin CC, Wu TC, Hobbs BP, Pestana RC, Hong DS. Moving Beyond 3+3: The Future of Clinical Trial Design. Am Soc Clin Oncol Educ Book. 2021 Jun; 41:e133-e144. PMID: 34061563.
      Citations: 1     Fields:    Translation:Humans
    13. Moll M, Zon RL, Sylvester KW, Rimsans J, Chen EC, Ghosh AJ, Abston E, Kim A, Rutherford H, Mitre X, Hakim A, Connell NT, Battinelli E, Fredenburgh LE, Baron RM, Hobbs BD, Cho MH, Mittleman MA, Woolley AE, Connors JM. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis. Thromb Res. 2021 07; 203:57-60. PMID: 33940309.
      Citations: 2     Fields:    Translation:HumansCells
    14. Shah C, Jia X, Hobbs BP, Tendulkar RD, Sittenfeld SMC, Al-Hilli Z, Arthur DW, Keisch ME, Khan AJ, Shaitelman SF, Boyages J, Wazer D, Kundu N, Vicini FA. Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis. Ann Surg Oncol. 2021 Sep; 28(9):4985-4994. PMID: 33393051.
      Citations: 1     Fields:    Translation:Humans
    15. Sussman TA, Li H, Hobbs B, Funchain P, McCrae KR, Khorana AA. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival. J Immunother Cancer. 2021 01; 9(1). PMID: 33436486.
      Citations: 15     Fields:    Translation:Humans
    16. Kaizer AM, Koopmeiners JS, Chen N, Hobbs BP. Statistical design considerations for trials that study multiple indications. Stat Methods Med Res. 2021 03; 30(3):785-798. PMID: 33267746.
      Citations: 1     Fields:    Translation:Humans
    17. McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, O'Connor E, Walsh S, Cho MH, Curley GF, McElvaney NG. Corrigendum to 'A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19'. EBioMedicine. 2020 Dec; 62:103116. PMID: 33181463.
      Citations:    Fields:    
    18. Theelen WSME, Chen D, Verma V, Hobbs BP, Peulen HMU, Aerts JGJV, Bahce I, Niemeijer ALN, Chang JY, de Groot PM, Nguyen QN, Comeaux NI, Simon GR, Skoulidis F, Lin SH, He K, Patel R, Heymach J, Baas P, Welsh JW. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Respir Med. 2021 05; 9(5):467-475. PMID: 33096027.
      Citations: 55     Fields:    Translation:Humans
    19. McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, O'Connor E, Walsh S, Cho MH, Curley GF, McElvaney NG. A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine. 2020 Nov; 61:103026. PMID: 33039714.
      Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
    20. Milton DR, Lin SH, Hobbs BP. Comparing Radiation Modalities with Trimodality Therapy Using Total Toxicity Burden. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):1001-1005. PMID: 32698967.
      Citations:    Fields:    Translation:Humans
    21. Shah C, Hobbs BP, Vicini F, Al-Hilli Z, Manyam BV, Verma V, Jia X, Goldstein N, Recht A. The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis. Ann Surg Oncol. 2020 Nov; 27(12):4628-4636. PMID: 32712894.
      Citations: 1     Fields:    Translation:Humans
    22. Franciosi AN, Hobbs BD, McElvaney OJ, Molloy K, Hersh C, Clarke L, Gunaratnam C, Silverman EK, Carroll TP, McElvaney NG. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med. 2020 07 01; 202(1):73-82. PMID: 32197047.
      Citations: 6     Fields:    Translation:Humans
    23. Zabor EC, Kaizer AM, Hobbs BP. Randomized Controlled Trials. Chest. 2020 07; 158(1S):S79-S87. PMID: 32658656.
      Citations: 2     Fields:    Translation:Humans
    24. Pestana RC, Sen S, Hobbs BP, Hong DS. Histology-agnostic drug development - considering issues beyond the tissue. Nat Rev Clin Oncol. 2020 09; 17(9):555-568. PMID: 32528101.
      Citations: 12     Fields:    Translation:Humans
    25. Statler AB, Wei W, Gupta A, Blake CN, Hobbs BP, Nahleh ZA. Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis. Clin Breast Cancer. 2020 10; 20(5):e625-e650. PMID: 32434711.
      Citations: 1     Fields:    Translation:Humans
    26. Hearn JWD, Sweeney CJ, Almassi N, Reichard CA, Reddy CA, Li H, Hobbs B, Jarrard DF, Chen YH, Dreicer R, Garcia JA, Carducci MA, DiPaola RS, Sharifi N. HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer. JAMA Oncol. 2020 04 01; 6(4):e196496. PMID: 32053149.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    27. Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol. 2020 05 10; 38(14):1569-1579. PMID: 32160096.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    28. Statler AB, Hobbs BP, Wei W, Gupta A, Blake CN, Nahleh ZA. Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis. Sci Rep. 2019 12 02; 9(1):18126. PMID: 31792304.
      Citations: 7     Fields:    Translation:Humans
    29. Kaizer AM, Koopmeiners JS, Kane MJ, Roychoudhury S, Hong DS, Hobbs BP. Basket Designs: Statistical Considerations for Oncology Trials. JCO Precis Oncol. 2019 Dec; 3:1-9. PMID: 35100726.
      Citations:    Fields:    
    30. Sisk BA, Dubois J, Hobbs BP, Kodish E. Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research. Ethics Hum Res. 2019 Nov; 41(6):2-11. PMID: 31743629.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    31. Ragland MF, Benway CJ, Lutz SM, Bowler RP, Hecker J, Hokanson JE, Crapo JD, Castaldi PJ, DeMeo DL, Hersh CP, Hobbs BD, Lange C, Beaty TH, Cho MH, Silverman EK. Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene. Am J Respir Crit Care Med. 2019 09 15; 200(6):677-690. PMID: 30908940.
      Citations: 23     Fields:    Translation:Humans
    32. Moreno AC, Fellman B, Hobbs BP, Liao Z, Gomez DR, Chen A, Hahn SM, Chang JY, Lin SH. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC. J Thorac Oncol. 2020 01; 15(1):101-109. PMID: 31479748.
      Citations: 12     Fields:    Translation:Humans
    33. Sharma M, Schilero C, Peereboom DM, Hobbs BP, Elson P, Stevens GHJ, McCrae K, Nixon AB, Ahluwalia MS. Phase II study of Dovitinib in recurrent glioblastoma. J Neurooncol. 2019 Sep; 144(2):359-368. PMID: 31292802.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    34. Lutz SM, Frederiksen B, Begum F, McDonald MN, Cho MH, Hobbs BD, Parker MM, DeMeo DL, Hersh CP, Ehringer MA, Young K, Jiang L, Foreman MG, Kinney GL, Make BJ, Lomas DA, Bakke P, Gulsvik A, Crapo JD, Silverman EK, Beaty TH, Hokanson JE. Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. Nicotine Tob Res. 2019 05 21; 21(6):714-722. PMID: 29767774.
      Citations: 6     Fields:    Translation:Humans
    35. Ornstein MC, Wood LS, Hobbs BP, Allman KD, Martin A, Bevan M, Gilligan TD, Garcia JA, Rini BI. A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy. J Immunother Cancer. 2019 05 16; 7(1):127. PMID: 31097024.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    36. Khorana AA, Tullio K, Elson P, Pennell NA, Grobmyer SR, Kalady MF, Raymond D, Abraham J, Klein EA, Walsh RM, Monteleone EE, Wei W, Hobbs B, Bolwell BJ. Time to initial cancer treatment in the United States and association with survival over time: An observational study. PLoS One. 2019; 14(3):e0213209. PMID: 30822350.
      Citations: 44     Fields:    Translation:Humans
    37. Ma J, Stingo FC, Hobbs BP. Bayesian personalized treatment selection strategies that integrate predictive with prognostic determinants. Biom J. 2019 07; 61(4):902-917. PMID: 30786040.
      Citations: 2     Fields:    Translation:Humans
    38. Hobbs BP, Barata PC, Kanjanapan Y, Paller CJ, Perlmutter J, Pond GR, Prowell TM, Rubin EH, Seymour LK, Wages NA, Yap TA, Feltquate D, Garrett-Mayer E, Grossman W, Hong DS, Ivy SP, Siu LL, Reeves SA, Rosner GL. Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology. J Natl Cancer Inst. 2019 02 01; 111(2):118-128. PMID: 30561713.
      Citations: 10     Fields:    Translation:Humans
    39. Wang Y, Hu J, Ng CS, Hobbs BP. A functional model for classifying metastatic lesions integrating scans and biomarkers. Stat Methods Med Res. 2020 01; 29(1):137-150. PMID: 30672395.
      Citations:    Fields:    Translation:Humans
    40. Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer. 2019 02 01; 125(3):365-373. PMID: 30359480.
      Citations: 5     Fields:    Translation:Humans
    41. Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2018 12 01; 24(23):5883-5894. PMID: 30082477.
      Citations: 31     Fields:    Translation:HumansCells
    42. Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, Saltz LB, Mazard T, Vauthey JN, Hoff PM, Hobbs B, Loyer EM, Kopetz S. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J Natl Cancer Inst. 2018 08 01; 110(8):888-894. PMID: 29346573.
      Citations: 9     Fields:    Translation:Humans
    43. Huang M, Hobbs BP. Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies. Stat Methods Med Res. 2019 09; 28(9):2820-2833. PMID: 30037304.
      Citations:    Fields:    Translation:Humans
    44. Hobbs BP, Landin R. Bayesian basket trial design with exchangeability monitoring. Stat Med. 2018 11 10; 37(25):3557-3572. PMID: 29984488.
      Citations: 15     Fields:    Translation:Humans
    45. Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier ND, Lee JE, Prieto VG, Hobbs BP. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol. 2018 08; 211(2):W109-W115. PMID: 29949418.
      Citations: 3     Fields:    Translation:Humans
    46. Li X, Guindani M, Ng CS, Hobbs BP. Spatial Bayesian modeling of GLCM with application to malignant lesion characterization. J Appl Stat. 2018; 46(2):230-246. PMID: 31439980.
      Citations: 4     
    47. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951. PMID: 28549010.
      Citations: 46     Fields:    Translation:HumansCTClinical Trials
    48. Ghosh P, Chandler AG, Hobbs BP, Sun J, Rong J, Hong D, Subbiah V, Janku F, Naing A, Hwu WJ, Ng CS. Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors. J Comput Assist Tomogr. 2018 May/Jun; 42(3):357-364. PMID: 29189398.
      Citations:    Fields:    Translation:Humans
    49. Kaizer AM, Koopmeiners JS, Hobbs BP. Bayesian hierarchical modeling based on multisource exchangeability. Biostatistics. 2018 04 01; 19(2):169-184. PMID: 29036300.
      Citations: 7     Fields:    Translation:Humans
    50. Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH. Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):996-1001. PMID: 29685377.
      Citations: 16     Fields:    Translation:HumansCells
    51. Ng CS, Wei W, Altinmakas E, Li X, Ghosh P, Perrier NA, Grubbs E, Prieto VG, Lee JE, Hobbs BP. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models. AJR Am J Roentgenol. 2018 Apr; 210(4):W156-W163. PMID: 29412015.
      Citations: 3     Fields:    Translation:Humans
    52. Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier NA, Prieto VG, Lee JE, Hobbs BP. Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance. Acad Radiol. 2018 07; 25(7):861-868. PMID: 29398440.
      Citations: 3     Fields:    Translation:Humans
    53. Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, Koay EJ. Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep. 2018 01 31; 8(1):1922. PMID: 29386574.
      Citations: 44     Fields:    Translation:HumansCells
    54. Kaizer AM, Hobbs BP, Koopmeiners JS. A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics. 2018 09; 74(3):1082-1094. PMID: 29359450.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    55. Fang P, Shiraishi Y, Verma V, Jiang W, Song J, Hobbs BP, Lin SH. Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation. Int J Part Ther. 2018; 4(3):23-32. PMID: 30079369.
      Citations: 30     
    56. Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V. Tree-based Methods for Characterizing Tumor Density Heterogeneity. Pac Symp Biocomput. 2018; 23:216-227. PMID: 29218883.
      Citations: 5     Fields:    Translation:Humans
    57. Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SH. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol. 2018 07; 128(1):154-160. PMID: 29248170.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    58. Yu W, Tang C, Hobbs BP, Li X, Koay EJ, Wistuba II, Sepesi B, Behrens C, Rodriguez Canales J, Parra Cuentas ER, Erasmus JJ, Court LE, Chang JY. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1090-1097. PMID: 29246722.
      Citations: 23     Fields:    Translation:Humans
    59. Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer. Clin Cancer Res. 2018 01 15; 24(2):341-350. PMID: 29030353.
      Citations: 16     Fields:    Translation:Humans
    60. Xu C, Xi M, Komaki R, Balter PA, Huang M, Hobbs BP, Wang L, Lin SH. Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):325-332. PMID: 29114599.
      Citations: 3     
    61. Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs BP, Huang M, Komaki R, Lin SH. Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old. Int J Radiat Oncol Biol Phys. 2017 07 15; 98(4):811-819. PMID: 28602412.
      Citations: 15     Fields:    Translation:Humans
    62. Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017 Jun; 43(6):785-794. PMID: 28197679.
      Citations: 17     Fields:    Translation:Humans
    63. Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY). 2017 02; 42(2):577-584. PMID: 27665482.
      Citations: 2     Fields:    Translation:Humans
    64. Ma J, Hobbs BP, Stingo FC. Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. Stat Methods Med Res. 2018 07; 27(7):2093-2113. PMID: 27807177.
      Citations: 2     Fields:    Translation:Humans
    65. Koopmeiners JS, Hobbs BP. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials. Stat Methods Med Res. 2018 05; 27(5):1547-1558. PMID: 27587591.
      Citations: 2     Fields:    Translation:Humans
    66. Zhao H, Hobbs BP, Ma H, Jiang Q, Carlin BP. Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors. Health Serv Outcomes Res Methodol. 2016 Sep; 16(3):154-171. PMID: 28458614.
    67. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope. 2017 04; 127(4):842-848. PMID: 27440393.
      Citations: 14     Fields:    Translation:Humans
    68. Fronczyk KM, Guindani M, Hobbs BP, Ng CS, Vannucci M. A Bayesian Nonparametric Approach for Functional Data Classification with Application to Hepatic Tissue Characterization. Cancer Inform. 2015; 14(Suppl 5):151-62. PMID: 27279730.
    69. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol. 2016 Apr 01; 34(10):1072-8. PMID: 26811528.
      Citations: 138     Fields:    Translation:Humans
    70. Hobbs BP, Chen N, Lee JJ. Controlled multi-arm platform design using predictive probability. Stat Methods Med Res. 2018 01; 27(1):65-78. PMID: 26763586.
      Citations: 25     Fields:    
    71. Etchebehere EC, Hobbs BP, Milton DR, Malawi O, Patel S, Benjamin RS, Macapinlac HA. Assessing the role of ¹8F-FDG PET and ¹8F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2016 May; 43(5):860-870. PMID: 26631240.
      Citations: 9     Fields:    Translation:Humans
    72. Kamali F, Wang WL, Guadagnolo BA, Fox PS, Lewis VO, Lazar AJ, Conley AP, Ravi V, Toliyat M, Ladha HS, Hobbs BP, Amini B. MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours. Br J Radiol. 2016; 89(1058):20150308. PMID: 26577289.
      Citations: 6     Fields:    Translation:Humans
    73. Ma J, Stingo FC, Hobbs BP. Bayesian predictive modeling for genomic based personalized treatment selection. Biometrics. 2016 06; 72(2):575-83. PMID: 26575856.
      Citations: 6     Fields:    Translation:Humans
      Citations: 2     
    75. Hobbs BP, Thall PF, Lin SH. Bayesian Group Sequential Clinical Trial Design using Total Toxicity Burden and Progression-Free Survival. J R Stat Soc Ser C Appl Stat. 2016 02; 65(2):273-297. PMID: 27034510.
      Citations: 11     
    76. Azadeh S, Hobbs BP, Ma L, Nielsen DA, Gerard Moeller F, Baladandayuthapani V. Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. Neuroimage. 2016 Jan 15; 125:813-824. PMID: 26484829.
      Citations: 3     Fields:    Translation:Humans
    77. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed. 2015 Dec; 28(12):1645-54. PMID: 26451969.
      Citations: 22     Fields:    Translation:Cells
    78. Wang Y, Hobbs BP, Ng CS. CT Perfusion Characteristics Identify Metastatic Sites in Liver. Biomed Res Int. 2015; 2015:120749. PMID: 26509144.
      Citations: 3     Fields:    Translation:Humans
    79. Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol. 2016 Feb; 23(2):482-9. PMID: 26416712.
      Citations: 8     Fields:    Translation:Humans
    80. Ma J, Hobbs BP, Stingo FC. Statistical Methods for Establishing Personalized Treatment Rules in Oncology. Biomed Res Int. 2015; 2015:670691. PMID: 26446492.
      Citations: 7     Fields:    Translation:Humans
    81. Cho MH, Castaldi PJ, Hersh CP, Hobbs BD, Barr RG, Tal-Singer R, Bakke P, Gulsvik A, San José Estépar R, Van Beek EJ, Coxson HO, Lynch DA, Washko GR, Laird NM, Crapo JD, Beaty TH, Silverman EK. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. Am J Respir Crit Care Med. 2015 Sep 01; 192(5):559-69. PMID: 26030696.
      Citations: 72     Fields:    Translation:Humans
    82. Raghav KP, Mahajan S, Yao JC, Hobbs BP, Berry DA, Pentz RD, Tam A, Hong WK, Ellis LM, Abbruzzese J, Overman MJ. From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology. J Clin Oncol. 2015 Nov 01; 33(31):3583-90. PMID: 26304898.
      Citations: 18     Fields:    Translation:Humans
    83. Rohren EM, Etchebehere EC, Araujo JC, Hobbs BP, Swanston NM, Everding M, Moody T, Macapinlac HA. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT. J Nucl Med. 2015 Oct; 56(10):1507-12. PMID: 26135112.
      Citations: 31     Fields:    Translation:Humans
    84. Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V. Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One. 2015; 10(6):e0131095. PMID: 26098849.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    85. Hobbs BP. On nonparametric hazard estimation. J Biom Biostat. 2015; 6. PMID: 26509102.
    86. Hobbs BP, Ng CS. Inferring Stable Acquisition Durations for Applications of Perfusion Imaging in Oncology. Cancer Inform. 2015; 14(Suppl 2):193-9. PMID: 26052222.
      Citations: 1     
    87. Murray TA, Hobbs BP, Sargent DJ, Carlin BP. Flexible Bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effects. Bayesian Anal. 2016 Jun; 11(2):381-402. PMID: 27042243.
      Citations: 3     
    88. Ng CS, Hobbs BP, Wei W, Anderson EF, Herron DH, Yao JC, Chandler AG. Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver. J Comput Assist Tomogr. 2015 May-Jun; 39(3):373-82. PMID: 25626401.
      Citations: 4     Fields:    Translation:Humans
    89. Wang Y, Hobbs BP, Hu J, Ng CS, Do KA. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Biometrics. 2015 Sep; 71(3):792-802. PMID: 25851056.
      Citations: 3     Fields:    Translation:Humans
    90. Tan CH, Hobbs BP, Wei W, Kundra V. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2015 Apr; 204(4):W439-48. PMID: 25794093.
      Citations: 34     Fields:    Translation:Humans
    91. Castillo SJ, Castillo R, Castillo E, Pan T, Ibbott G, Balter P, Hobbs B, Guerrero T. Evaluation of 4D CT acquisition methods designed to reduce artifacts. J Appl Clin Med Phys. 2015 Mar 08; 16(2):4949. PMID: 26103169.
      Citations: 7     Fields:    Translation:Humans
    92. Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2015 Feb; 150(2):137-43. PMID: 25517573.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    93. Castillo R, Pham N, Castillo E, Aso-Gonzalez S, Ansari S, Hobbs B, Palacio D, Skinner H, Guerrero TM. Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis. Radiology. 2015 Jun; 275(3):822-31. PMID: 25584706.
      Citations: 10     Fields:    Translation:Humans
    94. Ng CS, Chandler AG, Yao JC, Herron DH, Anderson EF, Charnsangavej C, Hobbs BP. Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors. J Comput Assist Tomogr. 2014 Jul-Aug; 38(4):526-34. PMID: 24651739.
      Citations: 4     Fields:    Translation:Humans
    95. Castillo SJ, Castillo R, Balter P, Pan T, Ibbott G, Hobbs B, Yuan Y, Guerrero T. Assessment of a quantitative metric for 4D CT artifact evaluation by observer consensus. J Appl Clin Med Phys. 2014 May 08; 15(3):4718. PMID: 24892346.
      Citations: 3     Fields:    Translation:Humans
    96. Amini B, Madewell JE, Chuang HH, Haygood TM, Hobbs BP, Fox PS, Bassett RL, Costelloe CM. Differentiation of Benign Fluid Collections from Soft-Tissue Sarcomas on FDG-PET/CT. J Cancer. 2014; 5(5):328-35. PMID: 24723975.
      Citations: 6     
    97. Castillo R, Pham N, Ansari S, Meshkov D, Castillo S, Li M, Olanrewaju A, Hobbs B, Castillo E, Guerrero T. Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer. Radiat Oncol. 2014 Mar 13; 9:74. PMID: 24625207.
      Citations: 20     Fields:    Translation:Humans
    98. Ridge CA, Hobbs BD, Bukoye BA, Aronson MD, Boiselle PM, Leffler DA, Sternberg SB, Roberts DH. Incidentally detected lung nodules: clinical predictors of adherence to Fleischner Society surveillance guidelines. J Comput Assist Tomogr. 2014 Jan-Feb; 38(1):89-95. PMID: 24424558.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    99. Murray TA, Hobbs BP, Lystig TC, Carlin BP. Semiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical data. Biometrics. 2014 Mar; 70(1):185-91. PMID: 24308779.
      Citations: 9     Fields:    Translation:Humans
    100. Ng CS, Hobbs BP, Chandler AG, Anderson EF, Herron DH, Charnsangavej C, Yao J. Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. Radiology. 2013 Dec; 269(3):758-67. PMID: 23824990.
      Citations: 15     Fields:    Translation:Humans
    101. Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L. Use of historical control data for assessing treatment effects in clinical trials. Pharm Stat. 2014 Jan-Feb; 13(1):41-54. PMID: 23913901.
      Citations: 79     Fields:    Translation:Humans
    102. Rauch GM, Kuerer HM, Scoggins ME, Fox PS, Benveniste AP, Park YM, Lari SA, Hobbs BP, Adrada BE, Krishnamurthy S, Yang WT. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat. 2013 Jun; 139(3):639-47. PMID: 23774990.
      Citations: 10     Fields:    Translation:Humans
    103. Nute JL, Rong J, Stevens DM, Darensbourg BJ, Cheng J, Wei W, Hobbs BP, Cody DD. Evaluation of over 100 scanner-years of computed tomography daily quality control data. Med Phys. 2013 May; 40(5):051908. PMID: 23635278.
      Citations: 2     Fields:    
    104. Hobbs BP, Carlin BP, Sargent DJ. Adaptive adjustment of the randomization ratio using historical control data. Clin Trials. 2013; 10(3):430-40. PMID: 23690095.
      Citations: 24     Fields:    Translation:Humans
    105. Schellingerhout D, LeRoux LG, Hobbs BP, Bredow S. Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging. PLoS One. 2012; 7(9):e45776. PMID: 23029238.
      Citations: 7     Fields:    Translation:AnimalsCells
    106. Hobbs BP, Sargent DJ, Carlin BP. Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models. Bayesian Anal. 2012 Aug 28; 7(3):639-674. PMID: 24795786.
      Citations: 31     
    107. Hobbs BP, Carlin BP, Mandrekar SJ, Sargent DJ. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials. Biometrics. 2011 Sep; 67(3):1047-56. PMID: 21361892.
      Citations: 51     Fields:    Translation:Humans
    108. Hobbs BP, Carlin BP. Practical Bayesian design and analysis for drug and device clinical trials. J Biopharm Stat. 2008; 18(1):54-80. PMID: 18161542.
      Citations: 13     Fields:    Translation:Humans
    109. Flynn D, van Schaik P, Blackman T, Femcott C, Hobbs B, Calderon C. Developing a virtual reality-based methodology for people with dementia: a feasibility study. Cyberpsychol Behav. 2003 Dec; 6(6):591-611. PMID: 14756925.
      Citations: 15     Fields:    Translation:Humans
    110. Combining non-randomized and randomized data in clinical trials using commensurate priors. Health Services and Outcomes Research Methodology. 16:154-171.
    111. Evaluation of 4D CT acquisition methods designed to reduce artifacts. Journal of Applied Clinical Medical Physics. 16:23-32.
    112. Integrative Bayesian analysis of neuroimaging-genetic data through hierarchical dimension reduction. 824-828.
    113. Flexible bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effects. Bayesian Analysis. 11:381-402.
    114. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast. Annals of Surgical Oncology. 23:482-489.
    115. Bayesian group sequential clinical trial design using total toxicity burden and progression-free survival. Journal of the Royal Statistical Society. Series C: Applied Statistics. 65:273-297.
    116. Statistical Methods for Establishing Personalized Treatment Rules in Oncology. BioMed Research International. 2015.
    117. Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. NeuroImage. 125:813-824.
    118. Differentiation of benign fluid collections from soft-tissue sarcomas on FDG-PET/CT. Journal of Cancer. 5:328-335.
    119. Assessment of a quantitative metric for 4D CT artifact evaluation by observer consensus. Journal of Applied Clinical Medical Physics. 15:190-201.
    120. Tumor T<inf>1</inf> relaxation time for assessing response to bevacizumab anti-angiogenic therapy in a mouse ovarian cancer model. PLoS One. 10.
    121. Combining nonexchangeable functional or survival data sources in oncology using generalized mixture commensurate priors. Annals of Applied Statistics. 9:1549-1570.
    122. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature. Scientific Reports. 6.
    123. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx. NMR in Biomedicine.
    124. Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes. Journal of Clinical Oncology. 34:1072-1078.
    125. Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging. Biometrics.
    126. Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models. Bayesian Analysis. 7:639-674.
    127. CT perfusion characteristics identify metastatic sites in liver. BioMed Research International. 2015.
    128. Abdominal Radiology. 1-8.
    129. Assessing the role of 18F-FDG PET and 18F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies. European Journal of Nuclear Medicine and Molecular Imaging. 1-11.
    130. Inferring stable acquisition durations for applications of perfusion imaging in oncology. Cancer Informatics. 14:193-199.
    131. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope.
    HOBBS's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (367)
    Co-Authors (134)
    Similar People (60)
    Same Department Expand Description